The Government of Canada is investing more than $72 million to build 264 rental units in Québec and Lévis through the Apartment Construction Loan Program (ACLP).

This year's Super Bowl logo and art style feature a colorful ... Kevin Pedeaux, owner of CR Coffee Shop and operator of the St. Roch Market, agrees that the community is ready for the influx ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Local artists designed the flag for the county as part of a $90,000 contract with St. Louis-based marketing agency Elasticity ...

Roche (RHHBY) unveiled its proprietary, breakthrough sequencing by expansion technology, establishing a new category of next-generation sequencing. SBX chemistry, combined with an innovative ...

UBS analyst Matthew Weston maintained a Buy rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of CHF338.00. The company’s shares closed yesterday at $324.00.

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment ...

Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise Research Campus in Allston that could employ hundreds. The Roche ...

Day Three of Cheltenham Festival 2025 delivered once again with plenty of drama and big winners on St Patrick’s Thursday. It ...

Left guard is one of the New Orleans Saints’ most urgent positional needs heading into free agency and the draft. As the Saints look to fortify their offensive line with a key signing ...

The New Orleans Saints may need to add a piece to the offense this offseason. New Orleans fan-favorite tight end Juwan Johnson has spent his entire five-year National Football League career as a ...

Newleos Therapeutics is making its debut with $93.5 million aimed at developing safer and more effective neuroscience treatments with several clinical programs from Swiss major Roche in hand.